Dinoprostone vaginal slow-release system (Propess®) compared to expectant management in the active treatment of premature rupture of the membranes at term: impact on maternal and fetal outcomes

Background. Retrospective study of 744 women at the Virgen del Camino Hospital in Pamplona concerning two variants for the active treatment of premature rupture of the membranes (PROM). The main purpose of the study was to assess the differences between two variants for the active treatment of PROM...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta obstetricia et gynecologica Scandinavica 2008-01, Vol.87 (2), p.195-200
Hauptverfasser:	Larrañaga-Azcárate, Carlos, Campo-Molina, Gema, Felicitas Pérez-Rodríguez, Ana, Ezcurdia-Gurpegui, Miguel
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravaginal Adult Anti-Bacterial Agents - therapeutic use Biological and medical sciences caesarean section Cesarean Section - statistics & numerical data Delayed-Action Preparations - therapeutic use Delivery. Postpartum. Lactation Dinoprostone Dinoprostone - therapeutic use Diseases of mother, fetus and pregnancy Disorders Female Fetal Membranes, Premature Rupture - therapy Fever - drug therapy Gynecology. Andrology. Obstetrics Humans Labor Stage, First Labor, Induced Linear Models Medical sciences Oxytocics - therapeutic use Oxytocin - therapeutic use Parity Pregnancy Pregnancy. Fetus. Placenta premature rupture of the membranes prostaglandin Retrospective Studies Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!